NanoValent Pharmaceuticals, Inc.

Basic Information

910 Technology BLVD STE G
Bozeman, MT, 59718-4012

Company Profile

n/a

Additional Details

Field Value
DUNS: 788166986
Hubzone Owned: Y
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 2


  1. SBIR Phase II: Targeted Nanoparticle Delivery Agent for Treatment of Adult Leukemia

    Amount: $300,000.00

    This Small Business Innovation Research Phase II project will develop targeted nanoparticle delivery systems capable of delivering conventional cytotoxics preferentially to tumor cells. While therapeu ...

    SBIR Phase II 2013 National Science Foundation
  2. SBIR Phase I: Targeted Nanoparticle Delivery Agent for Treatment of Adult Leukemia

    Amount: $149,848.00

    This Small Business Innovation Research (SBIR) Phase I project aims to explore the application of a targeted nanodelivery system for both treatment and efficacy monitoring in patients with adult leuke ...

    SBIR Phase I 2012 National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government